The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha

Area of Science:

• Virology
• Immunology
• Oncology

Background:

• High-risk human papillomavirus (HPV), particularly types 16 and 18, are linked to over 95% of cervical cancers.
• HPV oncoproteins E6 and E7 are crucial for tumor development and persistence.
• Interferon-alpha (IFNα) is used therapeutically for HPV infections, but viruses possess evasion mechanisms.

Purpose of the Study:

• To investigate how HPV evades the effects of interferon.
• To elucidate the role of the HPV16 E7 oncoprotein in inhibiting IFNα-mediated antiviral responses.

Main Methods:

• Assessing the impact of HPV16 E7 expression on IFNα-inducible genes.
• Analyzing the formation and nuclear translocation of the interferon-stimulated gene factor 3 (ISGF3) transcription complex.
• Identifying protein-protein interactions between E7 and ISGF3 components using biochemical assays.

Main Results:

• HPV16 E7 inhibits the induction of IFNα-inducible genes but not IFNγ-inducible genes.
• E7 expression correlates with impaired ISGF3 complex formation and failure of p48 to translocate to the nucleus upon IFNα stimulation.
• A direct interaction between E7 (amino acids 17-37) and p48 was identified, disrupting IFNα signal transduction.

Conclusions:

• The HPV16 E7 oncoprotein targets p48, a key component of the IFNα signaling pathway.
• This interaction leads to the loss of IFNα-mediated signal transduction, representing a mechanism for HPV immune evasion.
• Understanding this interaction may reveal new therapeutic strategies against HPV infections.